American Century Companies Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$17.63 - $21.74 $42,241 - $52,089
2,396 Added 12.28%
21,912 $432,000
Q4 2023

Feb 13, 2024
BUY
$14.37 - $19.07 $280,444 - $372,170
19,516 New
19,516 $342,000
Q3 2023

Nov 13, 2023
BUY
$13.62 - $20.2 $133,258 - $197,636
9,784 Added 87.32%
20,989 $364,000
Q2 2023

Aug 14, 2023
BUY
$10.44 - $16.48 $116,980 - $184,658
11,205 New
11,205 $157,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $690M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email